A Semi-Supervised Learning Method for MiRNA-Disease Association Prediction Based on Variational Autoencoder.

Autor: Ji C, Wang Y, Gao Z, Li L, Ni J, Zheng C
Jazyk: angličtina
Zdroj: IEEE/ACM transactions on computational biology and bioinformatics [IEEE/ACM Trans Comput Biol Bioinform] 2022 Jul-Aug; Vol. 19 (4), pp. 2049-2059. Date of Electronic Publication: 2022 Aug 08.
DOI: 10.1109/TCBB.2021.3067338
Abstrakt: MicroRNAs (miRNAs) are a class of non-coding RNAs that play critical role in many biological processes, such as cell growth, development, differentiation and aging. Increasing studies have revealed that miRNAs are closely involved in many human diseases. Therefore, the prediction of miRNA-disease associations is of great significance to the study of the pathogenesis, diagnosis and intervention of human disease. However, biological experimentally methods are usually expensive in time and money, while computational methods can provide an efficient way to infer the underlying disease-related miRNAs. In this study, we propose a novel method to predict potential miRNA-disease associations, called SVAEMDA. Our method mainly consider the miRNA-disease association prediction as semi-supervised learning problem. SVAEMDA integrates disease semantic similarity, miRNA functional similarity and respective Gaussian interaction profile (GIP) similarities. The integrated similarities are used to learn the representations of diseases and miRNAs. SVAEMDA trains a variational autoencoder based predictor by using known miRNA-disease associations, with the form of concatenated dense vectors. Reconstruction probability of the predictor is used to measure the correlation of the miRNA-disease pairs. Experimental results show that SVAEMDA outperforms other stat-of-the-art methods. AUC values of SVAEMDA of global leave-one-out cross validation (LOOCV) and 5-fold cross validation (5-fold CV) are 0.9464 and 0.9428 respectively. In addition, case studies of three common human diseases indicate that SVAEMDA obtains 100 percent of the top 50 predicted candidates in the benchmark databases. Therefore, SVAEMDA can efficiently and accurately predict the potential associations between diseases and miRNAs.
Databáze: MEDLINE